5 ML sugammadex 100 MG/ML Injection

RxCUI
1727000
RxNorm name
5 ML sugammadex 100 MG/ML Injection
Display name
Sugammadex (Injectable)
Full name
5 ML sugammadex 100 MG/ML Injection
Term type
SCD
Status
Active
Strength
500 mg/5ml
Dose form
Injection 5 ml
Route
Injectable
Updated
2026-11-06 11:16:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012016
Active start
012016
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
sugammadex sodium100 MG / 1 MLsugammadexsugammadex

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
sugammadex1726988

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0781-3469-950781-3469Sugammadex sugammadexSandoz IncANDA214311
16729-727-0316729-727sugammadex sugammadexAccord Healthcare Inc.ANDA214306
25021-619-0525021-619Sugammadex Sugammadex SodiumSagent PharmaceuticalsANDA215575
31722-255-1031722-255Sugammadex SugammadexCamber Pharmaceuticals, Inc.ANDA214337
42677-312-1042677-312Sugammadex SugammadexShandong New Time Pharmaceutical Co., Ltd.ANDA215701
43598-925-3743598-925Sugammadex SugammadexDr. Reddy's Laboratories Inc.ANDA214236
55579-893-1055579-893sugammadex SUGAMMADEXSolupharm Pharmazeutische Erzeugnisse GmbHANDA215260
62756-079-0462756-079sugammadex sugammadexSun Pharmaceutical Industries, Inc.ANDA214319
67457-970-0567457-970Sugammadex SugammadexMylan Institutional LLCANDA213915
68083-442-1068083-442sugammadex sugammadexGland Pharma LimitedANDA214364
68462-696-5068462-696sugammadex sugammadexGLENMARK PHARMACEUTICALS INC., USAANDA214364
70069-893-1070069-893sugammadex sugammadexSomerset Therapeutics, LLCANDA215260
70710-1651-670710-1651Sugammadex SugammadexZydus Pharmaceuticals USA Inc.ANDA214290
70748-371-0270748-371Sugammadex SugammadexLupin Pharmaceuticals, Inc.ANDA214338
70771-1857-670771-1857Sugammadex SugammadexZydus Lifesciences LimitedANDA214290
72205-479-0272205-479Sugammadex SugammadexNovadoz Pharmaceuticals LLCANDA214368
72266-269-1072266-269sugammadex sugammadexFosun Pharma USA Inc.ANDA214364

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2143110781-3469Sugammadex sugammadexANDASandoz Inc
ANDA21430616729-727sugammadex sugammadexANDAAccord Healthcare Inc.
ANDA21557525021-619Sugammadex Sugammadex SodiumANDASagent Pharmaceuticals
ANDA21433731722-255Sugammadex SugammadexANDACamber Pharmaceuticals, Inc.
ANDA21570142677-312Sugammadex SugammadexANDAShandong New Time Pharmaceutical Co., Ltd.
ANDA21423643598-925Sugammadex SugammadexANDADr. Reddy's Laboratories Inc.
ANDA21526055579-893sugammadex SUGAMMADEXANDASolupharm Pharmazeutische Erzeugnisse GmbH
ANDA21431962756-079sugammadex sugammadexANDASun Pharmaceutical Industries, Inc.
ANDA21391567457-970Sugammadex SugammadexANDAMylan Institutional LLC
ANDA21436468083-442sugammadex sugammadexANDAGland Pharma Limited
ANDA21429070710-1651Sugammadex SugammadexANDAZydus Pharmaceuticals USA Inc.
ANDA21433870748-371Sugammadex SugammadexANDALupin Pharmaceuticals, Inc.
ANDA21436872205-479Sugammadex SugammadexANDANovadoz Pharmaceuticals LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 35 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00781346972rxnav_ndcsyes
00781346975rxnav_ndcsyes
00781346995rxnav_ndcsyes
16729072703rxnav_ndcsyes
16729072731rxnav_ndcsyes
25021061905rxnav_ndcsyes
31722025510rxnav_ndcsyes
31722025531rxnav_ndcsyes
42677031201rxnav_ndcsyes
42677031210rxnav_ndcsyes
43598092511rxnav_ndcsyes
43598092537rxnav_ndcsyes
55579089301rxnav_ndcsyes
55579089310rxnav_ndcsyes
62756007903rxnav_ndcsyes
62756007904rxnav_ndcsyes
66794025702rxnav_ndcsyes
66794025741rxnav_ndcsyes
67457097000rxnav_ndcsyes
67457097005rxnav_ndcsyes
68083044210rxnav_ndcsyes
68462069605rxnav_ndcsyes
68462069650rxnav_ndcsyes
70069089301rxnav_ndcsyes
70069089310rxnav_ndcsyes
70710165101rxnav_ndcsyes
70710165106rxnav_ndcsyes
70748037101rxnav_ndcsyes
70748037102rxnav_ndcsyes
70771185701rxnav_ndcsyes
70771185706rxnav_ndcsyes
72205047901rxnav_ndcsyes
72205047902rxnav_ndcsyes
72266026901rxnav_ndcsyes
72266026910rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SugammadexSUGAMMADEX SODIUMMullan Pharmaceutical Inc.5373abf1-c6ef-4295-9b2e-b07964b2fe372026-11-02Warnings, Adverse reactionsExact identifier
rxcui: 1727000
sugammadexSUGAMMADEXSolupharm Pharmazeutische Erzeugnisse GmbHc451d4dc-03f8-48d9-a848-6b2905122aa42026-09-23Warnings, Adverse reactionsExact identifier
ndc (package): 55579-893-10
ndc (product): 55579-893
ndc11 (package): 55579089301
ndc11 (package): 55579089310
rxcui: 1727000
sugammadexSUGAMMADEXAccord Healthcare Inc.57bf9b96-0550-b8e4-e063-6294a90a317b2026-08-05Warnings, Adverse reactionsExact identifier
ndc (package): 16729-727-03
ndc (product): 16729-727
ndc11 (package): 16729072703
rxcui: 1727000
sugammadexSUGAMMADEXSomerset Therapeutics, LLC70c00636-d4ba-4939-802c-9d5a92435c932026-08-03Warnings, Adverse reactionsExact identifier
ndc (package): 70069-893-10
ndc (product): 70069-893
ndc11 (package): 70069089301
ndc11 (package): 70069089310
rxcui: 1727000
SugammadexSUGAMMADEXLupin Pharmaceuticals, Inc.9f2e66d7-a5d2-4593-bb30-6d4a418381aa2026-07-31Warnings, Adverse reactionsExact identifier
ndc (package): 70748-371-02
ndc (product): 70748-371
ndc11 (package): 70748037101
ndc11 (package): 70748037102
rxcui: 1727000
sugammadexSUGAMMADEXGland Pharma Limitedc61ee55a-e61b-4d3c-9ebc-cbf57290e36c2026-07-28Warnings, Adverse reactionsExact identifier
ndc (package): 68083-442-10
ndc (product): 68083-442
ndc11 (package): 68083044210
rxcui: 1727000
sugammadexSUGAMMADEXGLENMARK PHARMACEUTICALS INC., USAe7897fc1-4553-460c-a29b-0bc91cd9ca102026-07-28Warnings, Adverse reactionsExact identifier
ndc (package): 68462-696-50
ndc (product): 68462-696
ndc11 (package): 68462069650
ndc11 (package): 68462069605
rxcui: 1727000
SugammadexSUGAMMADEXNovadoz Pharmaceuticals LLCab41ea1c-266f-421c-8fc4-6e7ff518a75d2026-07-09Warnings, Adverse reactionsExact identifier
ndc (package): 72205-479-02
ndc (product): 72205-479
ndc11 (package): 72205047902
ndc11 (package): 72205047901
rxcui: 1727000
sugammadexSUGAMMADEXSun Pharmaceutical Industries, Inc.55b2eb4e-4d77-c555-e063-6294a90abf9e2026-07-03Warnings, Adverse reactionsExact identifier
ndc (package): 62756-079-04
ndc (product): 62756-079
ndc11 (package): 62756007903
ndc11 (package): 62756007904
rxcui: 1727000
SugammadexSUGAMMADEXZydus Pharmaceuticals USA Inc.21028965-598b-4cfa-a614-5c28ed40306a2026-07-02Warnings, Adverse reactionsExact identifier
ndc (package): 70710-1651-6
ndc (product): 70710-1651
ndc11 (package): 70710165101
ndc11 (package): 70710165106
rxcui: 1727000
SugammadexSUGAMMADEXZydus Lifesciences Limitedb1ec2b5e-a571-4511-ab44-d4193441330a2026-07-02Exact identifier
ndc (package): 70771-1857-6
ndc (product): 70771-1857
ndc11 (package): 70771185706
ndc11 (package): 70771185701
rxcui: 1727000
SugammadexSUGAMMADEX SODIUMSagent Pharmaceuticals5b25f16e-726a-4464-88da-b188c2f4e0382026-06-16Warnings, Adverse reactionsExact identifier
ndc (package): 25021-619-05
ndc (product): 25021-619
ndc11 (package): 25021061905
rxcui: 1727000
SugammadexSUGAMMADEXCamber Pharmaceuticals, Inc.9adda802-fab2-40c1-9c2f-358debdfb2492026-05-30Warnings, Adverse reactionsExact identifier
ndc (package): 31722-255-10
ndc (product): 31722-255
ndc11 (package): 31722025510
rxcui: 1727000
sugammadexSUGAMMADEXFosun Pharma USA Inc.4f1c7cf8-3db7-3f92-e063-6394a90aece92026-04-03Warnings, Adverse reactionsExact identifier
ndc (package): 72266-269-10
ndc (product): 72266-269
ndc11 (package): 72266026901
ndc11 (package): 72266026910
rxcui: 1727000
BRIDIONSUGAMMADEXMerck Sharp & Dohme LLC5171d883-fe8f-482c-97ab-40b00975b64a2026-03-13Warnings, Adverse reactionsExact identifier
rxcui: 1727000
SugammadexSUGAMMADEXDr. Reddy's Laboratories Inc.4f90c37e-3505-0968-38fd-fc7e4dd66e822026-02-18Warnings, Adverse reactionsExact identifier
ndc (package): 43598-925-37
ndc (product): 43598-925
ndc11 (package): 43598092511
ndc11 (package): 43598092537
rxcui: 1727000
SugammadexSUGAMMADEXMylan Institutional LLCeb84def8-933b-4eba-b81f-30d40b1e3d8d2026-02-04Warnings, Adverse reactionsExact identifier
ndc (package): 67457-970-05
ndc (product): 67457-970
ndc11 (package): 67457097000
ndc11 (package): 67457097005
rxcui: 1727000
SugammadexSUGAMMADEXSandoz Inc6cf43d88-d410-439e-a2e5-e31086f14fc22026-01-31Warnings, Adverse reactionsExact identifier
ndc (package): 0781-3469-95
ndc (product): 0781-3469
ndc11 (package): 00781346995
ndc11 (package): 00781346972
rxcui: 1727000
SugammadexSUGAMMADEXShandong New Time Pharmaceutical Co., Ltd.56400560-a2df-4126-b424-9e4b91e53a8b2025-03-24Warnings, Adverse reactionsExact identifier
ndc (package): 42677-312-10
ndc (product): 42677-312
ndc11 (package): 42677031210
ndc11 (package): 42677031201
rxcui: 1727000

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5171d883-fe8f-482c-97ab-40b00975b64asugammadex 500 MG in 5 ML Injection [PSN] · 5 ML sugammadex 100 MG/ML Injection [SCD] · sugammadex 500 MG per 5 ML Injection [SY]326These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION ® (sugammadex) Injection, for intravenous use Initial U.S. Approval: 201520260313

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
c451d4dc-03f8-48d9-a848-6b2905122aa4These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Solupharm Pharmazeutische Erzeugnisse GmbH20260923
57bf9b96-0550-b8e4-e063-6294a90a317bThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015 Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information.Accord Healthcare Inc.20260805
70c00636-d4ba-4939-802c-9d5a92435c93These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Somerset Therapeutics, LLC | Solupharm Pharmazeutische Erzeugnisse GmbH20260803
9f2e66d7-a5d2-4593-bb30-6d4a418381aaThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX Injection, for intravenous use Initial U.S. Approval: 2015Lupin Pharmaceuticals, Inc. | LUPIN LIMITED20260731
c61ee55a-e61b-4d3c-9ebc-cbf57290e36cThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Gland Pharma Limited20260728
e7897fc1-4553-460c-a29b-0bc91cd9ca10These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015GLENMARK PHARMACEUTICALS INC., USA | Gland Pharma Limited20260728
ab41ea1c-266f-421c-8fc4-6e7ff518a75dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260728
70c00636-d4ba-4939-802c-9d5a92435c93These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval:2015Somerset Therapeutics, LLC | Solupharm Pharmazeutische Erzeugnisse GmbH20260711
ab41ea1c-266f-421c-8fc4-6e7ff518a75dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED20260709
55b2eb4e-4d77-c555-e063-6294a90abf9eThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sun Pharmaceutical Industries, Inc. | Wasserburger Arzneimittelwerk GmbH20260703
21028965-598b-4cfa-a614-5c28ed40306aThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited20260702
b1ec2b5e-a571-4511-ab44-d4193441330aSUGAMMADEX injection, for intravenous useZydus Lifesciences Limited20260702
5b25f16e-726a-4464-88da-b188c2f4e038These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sagent Pharmaceuticals20260616
9adda802-fab2-40c1-9c2f-358debdfb249These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Camber Pharmaceuticals, Inc. | Aspiro Pharma Limited20260530
4f1c7cf8-3db7-3f92-e063-6394a90aece9These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Fosun Pharma USA Inc.20260403
4f90c37e-3505-0968-38fd-fc7e4dd66e82These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015 .Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories Limited-FTO920260218
eb84def8-933b-4eba-b81f-30d40b1e3d8dThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION . SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Mylan Institutional LLC20260204
6cf43d88-d410-439e-a2e5-e31086f14fc2These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Sandoz Inc20260131
056afa51-c887-ecdf-e063-6394a90a49ffSUGAMMADEX INJECTION HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX INJECTION, for intravenous use Initial U.S. Approval: 2015Piramal Critical Care Inc.20250923
56400560-a2df-4126-b424-9e4b91e53a8bThese highlights do not include all the information needed to use SUGAMMADEX INJECTION safely and effectively. See full prescribing information for SUGAMMADEX INJECTION. SUGAMMADEX injection, for intravenous use Initial U.S. Approval: 2015Shandong New Time Pharmaceutical Co., Ltd.20250324

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCV03ABAntidotesATC1-4sugammadex
FDASPLD047408gamma-CyclodextrinsCHEMhas_chemical_structuresugammadex
MEDRTD000077122SugammadexCHEMhas_ingredientsugammadex

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH100 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY5 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA213915
CODESANDAANDA214236
CODESANDAANDA214290
CODESANDAANDA214306
CODESANDAANDA214311
CODESANDAANDA214319
CODESANDAANDA214337
CODESANDAANDA214338
CODESANDAANDA214364
CODESANDAANDA214368
CODESANDAANDA215260
CODESANDAANDA215575
CODESANDAANDA215701
CODESVUID4035292
NAMESPrescribable Synonymsugammadex 500 MG in 5 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceVeterans Health Administration National Drug File